Leukemia and lymphomas
Frequent isolation of ecotropic murine leukemia virus after x-ray irradiation of C57BL/6 mice and establishment of producer lymphoid cell lines from radiation-induced lymphomas.
6
Lymphomas and High-Level Expression of Murine Leukemia Viruses in CFW Mice
6
Common proviral integration region on mouse chromosome 7 in lymphomas and myelogenous leukemias induced by Friend murine leukemia virus.
8
Identification of a common viral integration region in Cas-Br-E murine leukemia virus-induced non-T-, non-B-cell lymphomas.
9
Idelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomas
6
Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
8
AHI-1: a novel signaling protein and potential therapeutic target in human leukemia and brain disorders
17
Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site.
11
Association of recombinant murine leukemia viruses of the class II genotype with spontaneous lymphomas in CWD mice.
10
Distinct helper virus requirements for Abelson murine leukemia virus-induced pre-B- and T-cell lymphomas.
11
Specificity of cell surface virus receptors on radiation leukemia virus and radiation-induced thymic lymphomas.
9
Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development?
6
flvi-1, a common integration domain of feline leukemia virus in naturally occurring lymphomas of a particular type.
8
Cellular DNA regions involved in the induction of rat thymic lymphomas (Mlvi-1, Mlvi-2, Mlvi-3, and c-myc) represent independent loci as determined by their chromosomal map location in the rat.
5
Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.
8
cancer
31
A 3' end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus.
7
Proviral genome of radiation leukemia virus: molecular cloning of biologically active proviral DNA and nucleotide sequence of its long terminal repeat.
5
Increased Induction of Osteopetrosis, but Unaltered Lymphomagenicity, by Murine Leukemia Virus SL3-3 after Mutation of a Nuclear Factor 1 Site in the Enhancer
10
Molecular cloning of osteoma-inducing replication-competent murine leukemia viruses from the RFB osteoma virus stock.
5